Vector Biomed Inc.
Gaithersburg, MD
- UEI
- XJUXGT62VKL5
- CAGE
- 9KQ82
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 910 Clopper Rd #200, Gaithersburg, MD 20878, USA
- Website
- vectorbiomed.com
- Founded
- 2021
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Production of a lentiviral vector | National Heart Lung and Blood Institute | $653,000 | |
| Services for the production and stability testing of clinical grade lentiviral vector, in support of the HHS, NIH,… | National Cancer Institute | $803,500 | |
| Production of a lentiviral vector, CX170 from vector biomed | National Heart Lung and Blood Institute | $611,500 | |
| Acquisition of services to obtain preclinical grade lentiviral vectors in support of the HHS, NIH, national cancer… | National Cancer Institute | $120,600 |
About Vector Biomed Inc.
Vector Biomed Inc. is a for-profit corporate entity located in Gaithersburg, Maryland, specializing in the production of advanced biological research materials, with a particular focus on lentiviral vector manufacturing. The company is registered in SAM.gov through January 24, 2026, and operates as a manufacturer of goods primarily serving biomedical research institutions. Their core competency appears to be producing specialized viral vectors for medical research, with a strong emphasis on oncology and cardiovascular disease applications.
The company has secured multiple federal contract awards from key National Institutes of Health (NIH) components, specifically the National Cancer Institute (NCI) and the National Heart Lung and Blood Institute (NHLBI). These contracts, all structured as purchase orders, involve highly specialized services including production of clinical and preclinical grade lentiviral vectors, stability testing, and vector manufacturing supporting investigational research. The contracts range in value from $120,600 to $803,500, with performance periods extending through 2028. Vector Biomed Inc. has been selected on a sole source basis for at least one contract due to its unique capability to utilize proprietary transfer plasmid backbones. The contracts consistently support research in areas such as genetically engineered myeloid cells for solid tumor malignancies and advanced vector design platforms. None of the contracts have been designated as small business set-asides, indicating the company's competitive capabilities in its specialized field.
Quick answers
What is Vector Biomed Inc.'s UEI?
Vector Biomed Inc.'s Unique Entity ID (UEI) in SAM.gov is XJUXGT62VKL5.
What is Vector Biomed Inc.'s CAGE code?
Vector Biomed Inc.'s CAGE code is 9KQ82.
What is Vector Biomed Inc.'s primary NAICS code?
Vector Biomed Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Vector Biomed Inc. located?
Vector Biomed Inc.'s physical address in SAM.gov is 910 Clopper Rd #200, Gaithersburg, MD 20878, USA.
Is Vector Biomed Inc. registered in SAM.gov?
Yes. Vector Biomed Inc.'s SAM.gov registration is active through December 3, 2026.
What is Vector Biomed Inc.'s most recent federal award?
Vector Biomed Inc.'s most recent federal contract award is Production of a lentiviral vector (75N92025P00404), from National Heart Lung and Blood Institute, on September 24, 2025.
On GovTribe
See Vector Biomed Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors